# SynAct Pharma AB – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/synact-pharma-ab
Company JSON: https://spela.port0.org/company/synact-pharma-ab/company.json
Documents JSON: https://spela.port0.org/company/synact-pharma-ab/documents.json
Updated: 2026-08-07T08:04:20Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/synact-pharma-ab/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/synact-pharma-ab/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/synact-pharma-ab/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/synact-pharma-ab/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/synact-pharma-ab/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/synact-pharma-ab/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/synact-pharma-ab/reports
- JSON: https://spela.port0.org/company/synact-pharma-ab/reports/reports.json
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b4dbd3f271989f587de7c9243c1fc78e8&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=b6a5a1ede73128c3217fb82c7e1b9a1cf&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=bc31286864fea797564f598cedd475419&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b7b6fd4c4508279a30ae185e81bf1b6b5&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b90dc6f2e84323bd7f31e7974e18f0898&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=ba8ac9ab3446edc51940e263080806c03&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b1214e81951fde15c9da3d2bcf8be9b16&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=bd249300c7365a92e6482feeacfdc0cab&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b97d88d92d29c13e7aa9b3d7bf24d8e25&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=b1d9932af6f1a16016e700cfcd7b14f9e&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=bddb5d73bca5448c9b63d6c335290d7db&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=b65e28271844cd29144b0e0f323241a74&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=b01eef9f2d05259bf2fb87a11839d9a60&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b1daab32671cfe3955a09678f5a63dc50&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=bbffe932055b30853e88c42b74068e2fa&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b5d5fd93f70f6245f363ac48eb576df2c&lang=sv&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/synact-pharma-ab/finansinspektionen
- Summary: https://spela.port0.org/company/synact-pharma-ab/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/synact-pharma-ab/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/synact-pharma-ab/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/synact-pharma-ab/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/synact-pharma-ab/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/synact-pharma-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/synact-pharma-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt